Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
X. Ruan & A. O. Mueck. (2023) The WHO claims estrogens are ‘carcinogenic’: is this true?. Climacteric 26:3, pages 263-270.
Read now
Read now
Y. Wang, H. Tahiri, C. Yang, M. Gu, X. Ruan & P. Hardy. (2023) Overexpression of miR-181a regulates the Warburg effect in triple-negative breast cancer. Climacteric 26:1, pages 64-71.
Read now
Read now
L. Zhang, X. Ruan, M. Gu & A. O. Mueck. (2022) E2 + norethisterone promotes the PI3K–AKT pathway via PGRMC1 to induce breast cancer cell proliferation. Climacteric 25:5, pages 467-475.
Read now
Read now
Andrea R. Genazzani, Patrizia Monteleone, Andrea Giannini & Tommaso Simoncini. (2021) Pharmacotherapeutic options for the treatment of menopausal symptoms. Expert Opinion on Pharmacotherapy 22:13, pages 1773-1791.
Read now
Read now
X. Li, X. Ruan, M. Gu & A. O. Mueck. (2019) PGRMC1 can trigger estrogen-dependent proliferation of breast cancer cells: estradiol vs. equilin vs. ethinylestradiol. Climacteric 22:5, pages 483-488.
Read now
Read now
Harald Seeger, Xiangyan Ruan, Hans Neubauer, Sara Brucker & Alfred O. Mueck. (2018) Membrane-initiated effects of Serelys® on proliferation and apoptosis of human breast cancer cells. Gynecological Endocrinology 34:4, pages 353-356.
Read now
Read now
Nicole C. Clark, Anne M. Friel, Cindy A. Pru, Ling Zhang, Toshi Shioda, Bo R. Rueda, John J. Peluso & James K. Pru. (2016) Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors. Cancer Biology & Therapy 17:3, pages 262-271.
Read now
Read now
Ying Zhang, Xiangyan Ruan, Marina Willibald, Harald Seeger, Tanja Fehm, Hans Neubauer & Alfred O. Mueck. (2016) May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?. Gynecological Endocrinology 32:1, pages 58-60.
Read now
Read now
L. M. Pompei, E. P. Cunha, M. L. Steiner, T. R. Theodoro, A. M. A. A. Mader, G. Petri, M. A. S. Pinhal & C. E. Fernandes. (2015) Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis. Climacteric 18:4, pages 518-522.
Read now
Read now
X. Ruan & A. O. Mueck. (2015) Impact of smoking on estrogenic efficacy. Climacteric 18:1, pages 38-46.
Read now
Read now
Shunyu Liu, Xiangyan Ruan, Silke Schultz, Hans Neubauer, Tanja Fehm, Harald Seeger & Alfred O. Mueck. (2015) Oestetrol stimulates proliferation and oestrogen receptor expression in breast cancer cell lines: Comparison of four oestrogens. The European Journal of Contraception & Reproductive Health Care 20:1, pages 29-35.
Read now
Read now
H. Neubauer, Q. Ma, J. Zhou, Q. Yu, X. Ruan, H. Seeger, T. Fehm & A. O. Mueck. (2013) Possible role of PGRMC1 in breast cancer development. Climacteric 16:5, pages 509-513.
Read now
Read now
Helen Schneck, Xiangyan Ruan, Harald Seeger, Michael A. Cahill, Tanja Fehm, Alfred O. Mueck & Hans Neubauer. (2013) Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecological Endocrinology 29:2, pages 160-162.
Read now
Read now
Articles from other publishers (28)
Valentina Lodde, Rodrigo Garcia Barros, Laura Terzaghi, Federica Franciosi & Alberto Maria Luciano. (2022) Insights on the Role of PGRMC1 in Mitotic and Meiotic Cell Division. Cancers 14:23, pages 5755.
Crossref
Crossref
James K Pru. (2022) Pleiotropic Actions of PGRMC Proteins in Cancer. Endocrinology 163:7.
Crossref
Crossref
Xiangyan Ruan & Alfred O. Mueck. (2022) Optimizing menopausal hormone therapy: for treatment and prevention, menstrual regulation, and reduction of possible risks. Global Health Journal 6:2, pages 61-69.
Crossref
Crossref
Yingxue Bai, Marina Ludescher, Gereon Poschmann, Kai Stühler, Martine Wyrich, Julia Oles, André Franken, Mahdi Rivandi, Anna Abramova, Florian Reinhardt, Eugen Ruckhäberle, Dieter Niederacher, Tanja Fehm, Michael A. Cahill, Nadia Stamm & Hans Neubauer. (2021) PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling. Cancers 13:22, pages 5635.
Crossref
Crossref
Diego A. Pedroza, Ramadevi Subramani, Kira Tiula, Anthony Do, Navya Rashiraj, Adriana Galvez, Animesh Chatterjee, Alejandra Bencomo, Servando Rivera & Rajkumar Lakshmanaswamy. (2021) Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation. Laboratory Investigation 101:6, pages 733-744.
Crossref
Crossref
Paul C.M. Piette. (2020) The pharmacodynamics and safety of progesterone. Best Practice & Research Clinical Obstetrics & Gynaecology 69, pages 13-29.
Crossref
Crossref
H.R. Motamed, M. Shariati, R. Ahmadi, S. Khatamsaz & M. Mokhtari. (2020) The apoptotic effects of progesterone on breast cancer (MCF-7) and human osteosarcoma (MG-636) cells. Physiology International 107:3, pages 406-418.
Crossref
Crossref
Guiju Cai, Xue Yang, Xiangyan Ruan, Jing Wang, Yi Fang, Yun Wei, Ying Zhang, Muqing Gu & Alfred O. Mueck. (2020) Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with PGRMC1 expression in breast tumour tissue and with clinical breast tumour characteristics. Maturitas 140, pages 64-71.
Crossref
Crossref
Nattawut Leelakanok & Janthima Methaneethorn. (2020) A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive. Clinical Drug Investigation 40:5, pages 395-420.
Crossref
Crossref
Xiangyan Ruan, Guiju Cai, Yun Wei, Muqing Gu, Ying Zhang, Yue Zhao & Alfred O. Mueck. (2020) Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers. Menopause 27:2, pages 183-193.
Crossref
Crossref
Nicole C. Lorona, Linda S. Cook, Mei-Tzu C. Tang, Deirdre A. Hill, Charles L. Wiggins & Christopher I. Li. (2019) Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer. Hormones and Cancer 10:2-3, pages 71-76.
Crossref
Crossref
Xiangyan Ruan, Muqing Gu, Guiju Cai, Yue Zhao, Lijuan Wang, Xue Li & Alfred O. Mueck. (2019) Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study. Maturitas 123, pages 1-8.
Crossref
Crossref
Xiangyan Ruan & Alfred O. Mueck. (2019) The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue. Hormone Molecular Biology and Clinical Investigation 37:1.
Crossref
Crossref
Craig S. Atwood & Samuel F. Ekstein. (2019) Human versus non-human sex steroid use in hormone replacement therapies part 1: Preclinical data. Molecular and Cellular Endocrinology 480, pages 12-35.
Crossref
Crossref
Marina Willibald, Giuliano Bayer, Vanessa Stahlhut, Gereon Poschmann, Kai Stühler, Berthold Gierke, Michael Pawlak, Harald Seeger, Alfred O. Mueck, Dieter Niederacher, Tanja Fehm & Hans Neubauer. (2017) Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells. Oncotarget 8:42, pages 72480-72493.
Crossref
Crossref
Yue Zhao, Xiangyan Ruan, Husheng Wang, Xue Li, Muqing Gu, Lijuan Wang, Yanglu Li, Harald Seeger & Alfred O. Mueck. (2017) The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model. Maturitas 102, pages 26-33.
Crossref
Crossref
Karolina Kociszewska & Piotr Czekaj. (2017) New Insight into Progesterone-dependent Signalization. Open Pharmaceutical Sciences Journal 4:1, pages 11-22.
Crossref
Crossref
Xiangyan Ruan, Ying Zhang, Alfred O. Mueck, Marina WillibaldHarald Seeger, Tanja FehmSara Brucker & Hans Neubauer. (2017) Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer. Menopause 24:2, pages 203-209.
Crossref
Crossref
Alfred O. Mueck. (2017) Transdermales Östradiol und ProgesteronTransdermal estradiol and progesterone. Gynäkologische Endokrinologie 15:1, pages 65-72.
Crossref
Crossref
Michael A. Cahill, Jalal A. Jazayeri, Susan M. Catalano, Shinya Toyokuni, Zaklina Kovacevic & Des R. Richardson. (2016) The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1866:2, pages 339-349.
Crossref
Crossref
Carlo Alberto Palmerini, Michela Mazzoni, Giorgia Radicioni, Valeria Marzano, Letizia Granieri, Federica Iavarone, Renato Longhi, Irene Messana, Tiziana Cabras, Maria Teresa Sanna, Massimo Castagnola & Alberto Vitali. (2016) Antagonistic Effect of a Salivary Proline-Rich Peptide on the Cytosolic Ca2+ Mobilization Induced by Progesterone in Oral Squamous Cancer Cells. PLOS ONE 11:1, pages e0147925.
Crossref
Crossref
S. Alouini, G. Venslauskaite & Z. Lubarskiene. (2015) Contraception with levonorgestrel system and risks of breast cancer. American Journal of Obstetrics and Gynecology 212:2, pages 255.
Crossref
Crossref
Anne M. Friel, Ling Zhang, Cindy A. Pru, Nicole C. Clark, Melissa L. McCallum, Leen J. Blok, Toshi Shioda, John J. Peluso, Bo R. Rueda & James K. Pru. (2015) Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors. Cancer Letters 356:2, pages 434-442.
Crossref
Crossref
A.O. Mueck, X. Ruan, H. Seeger, T. Fehm & H. Neubauer. (2014) Genomic and non-genomic actions of progestogens in the breast. The Journal of Steroid Biochemistry and Molecular Biology 142, pages 62-67.
Crossref
Crossref
Anusha Jayaraman & Christian J. Pike. (2014) Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons. Molecular and Cellular Endocrinology 384:1-2, pages 52-60.
Crossref
Crossref
Terrence K. Allen, Liping Feng, Chad A. Grotegut & Amy P. Murtha. (2014) Progesterone Receptor Membrane Component 1 as the Mediator of the Inhibitory Effect of Progestins on Cytokine-Induced Matrix Metalloproteinase 9 Activity In Vitro. Reproductive Sciences 21:2, pages 260-268.
Crossref
Crossref
Jing Zhou, Qi Yu, Rong Chen, Harald Seeger, Tanja Fehm, Michael A. Cahill, Alfred O. Mueck & Hans Neubauer. (2013) Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. Maturitas 76:2, pages 129-133.
Crossref
Crossref
Xiangyan Ruan, Harald Seeger & Alfred O. Mueck. (2012) The pharmacology of nomegestrol acetate. Maturitas 71:4, pages 345-353.
Crossref
Crossref